Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cationic and adsorbable orally administered drugs in the gastrointestinal lumen refers to a broad pharmacological category of medications that are susceptible to sequestration by non-absorbed binding agents within the digestive tract. This target class primarily includes drugs that possess a positive (cationic) charge or specific physicochemical properties that facilitate their adsorption or ion exchange with therapeutic resins and binders. These drugs are not biological targets in the traditional sense; rather, they represent a group of exogenous substances that can be bound by agents such as patiromer, sodium polystyrene sulfonate, or activated charcoal. When these drugs are co-administered with such binders, they may be trapped in the gastrointestinal lumen, preventing their absorption into the systemic circulation and significantly reducing their therapeutic efficacy. This interaction is a critical clinical consideration, particularly for patients on complex medication regimens, and typically necessitates a dosing separation of several hours to ensure adequate drug bioavailability.
Adsorption, ion exchange, and sequestration within the gastrointestinal tract.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cationic and adsorbable orally administered drugs in the gastrointestinal lumen.